Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Interleukin 15 (compound)
Most Correlated Studies
- L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
- L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
- L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
Most Relevant Literature
- IL-15 as a key regulator in NK cell-mediated immunotherapy for cancer: From bench to bedside.
- The role of interleukin-15 in the development and treatment of hematological malignancies.
- Interleukin-15 in kidney disease and therapeutics.
- Profibrogenic role of IL-15 through IL-15 receptor alpha-mediated trans-presentation in the carbon t…
- Interleukin-15 is a hair follicle immune privilege guardian.
Most Relevant Clinical Trials
- Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo
- Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cel…
- Serum and Tissue Level of Interleukin-15 (IL-15) and IL-15 Receptor Alpha (IL-15Rα) in Mycosis Fungo…
- Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in …
- GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblas…
